IPSEN SA ADR Cash Flow - Quarterly (OTCMKTS:IPSEY)

Add to My Stocks
$42.68 $1.27 (2.89%) IPSEY stock closing price Sep 18, 2018 (Closing)

The cash flow statement is one of the reports a publicly traded company like IPSEN SA ADR needs to disclose. The profit-loss statement shows IPSEN SA ADR profits, the balance sheet shows IPSEN SA ADR debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. IPSEN SA ADR saw a cash impact of $-11.98M from the buyback of IPSEY shares. The cash flow statement helps in the IPSEN SA ADR stock analysis by providing more information for evaluating changes in assets, liabilities and equities. IPSEN SA ADR has a negative cash and cash equivalents change of $-240.98M.

View and download details of IPSEN SA ADR cash flows for latest & last 40 quarters
show more
Fiscal year is Jan - Dec2017 Q42017 Q22016 Q42016 Q22015 Q4
Net Income Cash Flow
308.45M138.47M250.75M150.57M211.75M
Depreciation Depletion Amortization Cash-Flow119.58M58.62M43.26M5.76M48.52M
Net Increase (Decrease) in Assets Liabilities-23.96M-72.59M-0.99M-32.87M-90.05M
Cash From (used in) Discontinued Operations-----
Other Adjustments Net73.69M18.03M58.64M24.62M78.17M
Net Cash from (used by) Operating Activities
478M142.54M351.67M147.97M248.28M
Increase (Decrease) in Prop Plant And Equipment-95.51M-30.79M-85.87M-39.76M-55.29M
Acquisition Disposition of Subsidiaires-1.8M-0.76M-1.1M--
Increase (Decrease) in Investments-----
Other Cash Inflow (Outflow) from Investment Activities-781.03M-718.34M-308.18M-216.54M-62.62M
Net Cash from (used by) Investment Activities
-878.46M-750.13M-395.16M-256.19M-117.92M
Issuance (Purchase) of Equity Shares-11.98M--5.53M1.24M-18.87M
Issuance (Repayment) of Debt Securities-2.03M-1.31M358.53M355.71M-4.99M
Increase (Decrease) in Bank & Other Borrowings246.74M413.01M---
Payment of Dividends & Other Cash Distributions-79.34M-77.21M-77.46M-79.07M-77.72M
Other Cash from (used by) Financing Activities-0.56M-3.51M3.31M-1.01M-
Net Cash from (used by) Financing Activities
152.81M331.17M278.86M276.86M-101.26M
Effect of Exchange Rate Changes on Cash6.66M-0.43M-4.64M-4.4M8.43M
Net Change in Cash & Cash Equivalents
-240.98M-276.73M230.72M164.35M37.64M
Cash & Equivalents at Beginning of Year236.81M----
Cash & Equivalents at Year End236.57M187.97M467.53M406.09M237.62M
All figures in USD. M: Millions of USD, B: Billions of USD.

Click here to view our Grifols financial analysis

IPSEN SA ADR stock comparison chart provides an easy way to compare the stock price with peers along with details of IPSEN SA ADR stock price history.
The statement of cash flows can be categorized into the following main sections:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that IPSEN SA ADR is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - IPSEN SA ADR stock price movement.
  • Cash Flow from operating activities: IPSEN SA ADR reported a positive operating cash flow of $478M till 2017 Q4 and has seen an increase from the previous quarter. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-878.46M for IPSEY stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. IPSEN SA ADR earned $152.81M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For IPSEN SA ADR Cash Flow

Quarterly Cash Flow Statements For IPSEN SA ADR Peers

Grifols cash flow, Merck KGAA cash flow, UCB SA cash flow